SYSTEMIC SCLEROSIS
Clinical trials for SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could slow down devastating scleroderma
Disease control Not yet recruitingThis study tests a new oral medication called nerandomilast for people with systemic sclerosis (scleroderma), a disease that causes skin thickening and organ damage. About 448 adults will be randomly assigned to receive either the drug or a placebo twice daily for up to 4 years. …
Matched conditions: SYSTEMIC SCLEROSIS
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
500 volunteers help unlock secrets of autoimmune diseases
Knowledge-focused Not yet recruitingThis study collects medical information and biological samples from 450 adults with autoimmune diseases (rheumatoid arthritis, lupus, or scleroderma) and 50 healthy volunteers. Researchers will analyze blood and tissue samples to find patterns that could improve diagnosis and und…
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated May 01, 2026 15:23 UTC
-
Scleroderma Patients' sleep troubles under the microscope
Knowledge-focused Not yet recruitingThis study will monitor the sleep of 30 adults with systemic sclerosis (scleroderma) to see how often they have pauses in breathing during the night. Participants will spend one night in a sleep lab for detailed measurements. The goal is to better understand sleep problems in thi…
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC
-
Blood protein may reveal hidden heart risks in scleroderma patients
Knowledge-focused Not yet recruitingThis study looks at whether a protein called catestatin in the blood can help doctors understand heart and blood vessel damage in people with systemic sclerosis (a disease that causes hardening of the skin and internal organs). Researchers will compare catestatin levels in 70 adu…
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC